Boehringer Ingelheim’s commitment to serve humankind can be met if we are the preferred partner and admired competitor in three areas. Learn more here.
Faced with COVID-19, everyone has to adjust their lives, which can be challenging. This is especially true for healthcare professionals. Find out more.
Here you can find a discussion of the benefits offered by Pradaxa® for stroke prevention in patients with atrial fibrillation. Click here to learn more.
Anne and Franc, who are living with type 2 diabetes, explore what it means to live with their condition and its associated comorbidities. Find out more.
Atrial fibrillation (AF) is the most common cardiac rhythm disorder worldwide. Click here for more information on Stroke Prevention in atrial fibrillation.
Colleagues across Canada are doing their part during the pandemic by supporting their community’s needs. Click here to find out and learn more information.
UK donates to vulnerable children and local emergency fund
Find out how colleagues in the UK are helping disadvantaged young people in isolation, and supporting charities in the community. Click here to learn more.
Boehringer Ingelheim is driven by a purpose to positively impact the lives of communities in India. Click here to learn more about our work in this area.